<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05019092</url>
  </required_header>
  <id_info>
    <org_study_id>TVP_UTI_1</org_study_id>
    <nct_id>NCT05019092</nct_id>
  </id_info>
  <brief_title>Systematic Screening for Deep Vein Thrombosis in Critically Ill Patients</brief_title>
  <official_title>Potential Harms and Benefits of Systematic Screening for Deep Vein Thrombosis in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ettore Marini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Of Perugia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: venous thromboembolism (VTE) is a common complication in critically ill patients,&#xD;
      admitted to the Intensive Care Units (ICUs). At the present time, there is no validated score&#xD;
      to estimate risks and benefits of antithrombotic pharmacological prophylaxis in this subset&#xD;
      of patients.&#xD;
&#xD;
      Aim of the study: investigating potential harms and benefits of a protocol for systematic&#xD;
      screening of DVT in critically ill patients, admitted to an ICU.&#xD;
&#xD;
      Expected relevance: systematic screening for deep vein thrombosis (DVT) through ultrasound&#xD;
      (US) lower limb veins examination could help defining the indication to antithrombotic&#xD;
      pharmacological treatment, but no protocol of systematic screening has been validated so far.&#xD;
      Furthermore, the screening could be associated with over-diagnosis and consequent&#xD;
      over-treatment, as well as increased management burden for the caregivers and higher&#xD;
      healthcare costs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of deep vein thrombosis</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Diagnosis of deep vein thrombosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression of deep vein thrombosis (DVT)</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Extension of a previously diagnosed DVT to a more proximal site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prophylaxis/ treatment of venous thromboembolism (VTE)</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Necessity of prophylaxis/ treatment of VTE and its possible modifications during the stay in Intensive Care Unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of pulmonary embolism</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Findings of pulmonary embolism at contrast-enhanced CT scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of major bleeding</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>According to the definition of the International Society of Thrombosis and Hemostasis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of anemia</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Reduction of hemoglobin &gt;2 g/dL without evidence of active bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Duration of ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of death in ICU</measure>
    <time_frame>hospitalization in UTI, an average of 10 days</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of death within 3 months after hospital discharge</measure>
    <time_frame>Within 3 months after hospital discharge</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of new hospital admission within 3 months after hospital discharge</measure>
    <time_frame>Within 3 months after hospital discharge</time_frame>
    <description>New hospital admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <arm_group>
    <arm_group_label>Screening</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound (US) examination of lower limbs 48 hours after admission and again after 3-5 days (5-7 days after the admission)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Ultrasound (US) examination according to the clinical evaluation of risk factors for deep vein thrombosis (DVT) and life-threatening bleeding, based on the standard of care (SOC) of the enrolling institution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound examination of lower limb veins</intervention_name>
    <description>Ultrasound examination will be performed by trained physicians using a commercially available ultrasound system and 5.0-15.0 MHz linear probe. The examinations consists of a comprehensive B-mode ultrasound protocol, from thigh to ankle, employing compression and color-Doppler at selected sites, according to the Consensus Conference of the Society of Radiologists in Ultrasound.</description>
    <arm_group_label>Screening</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years old&#xD;
&#xD;
          -  Admission to the ICU&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  duration of stay in ICU &lt;5 days&#xD;
&#xD;
          -  SARS-CoV-2 infection&#xD;
&#xD;
          -  established DVT or pulmonary embolism at admission&#xD;
&#xD;
          -  established coagulation disorder&#xD;
&#xD;
          -  presence of inferior vena cava filter at the admission&#xD;
&#xD;
          -  admission/discharge to the ICU of another hospital&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonella Pasqualini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit√† degli Studi di Perugia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medicine Interna, Angiologia e Malattie da arteriosclerosi</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 5, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Of Perugia</investigator_affiliation>
    <investigator_full_name>Ettore Marini</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Authors agree to share IPD after publication of results. Data will be access on request to the corresponding Author.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After publication of results</ipd_time_frame>
    <ipd_access_criteria>Available on request, by the corresponding author</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

